Clinical Trial Update: Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial of decitabine delivered by hepatic arterial infusion for unresectable liver metastases from colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Liver Metastasis, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED